Advertisement

Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech

      Abstract

      Genomic DNAs from 35 Japanese sporadic patients with Rett syndrome (RTT) were screened for DNA mutations in the entire coding region and exon–intron boundaries of methyl-CpG-binding protein 2 (MECP2). We detected mutations in 30 (85.7%) of 35 patients. Among these 35 RTT patients, five patients (14%) had the preserved speech variant of this disease. Four respective mutations (R133C, R306C, R294X, 2 base pair (bp) deletion) were found in these five patients. Two patients had the same missense mutation, R133C. The patients with the R133C mutation and one with frameshift mutation presented the relatively mild clinical presentation, and the R133C mutation was not found in any other patient without preserved speech. We confirmed that the preserved speech variant is one of the clinical phenotypes of RTT and is also caused by MECP2 mutation. We speculated that the clinical phenotype of patients with the R133C missense mutation might be mild.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hagberg B.A.
        • Skjeldal O.H.
        Rett variants: a suggested model for inclusion criteria.
        Pediatr Neurol. 1994; 11: 5-11
        • Zappella M.
        The Rett girls with preserved speech.
        Brain Dev. 1992; 14: 98-101
        • Zappella M.
        • Gillberg C.
        • Ehlers S.
        The preserved speech variant: a subgroup of Rett complex: a clinical report of 30 cases.
        J Autism Dev Disord. 1998; 228: 519-526
        • Amir R.E.
        • Van den Veyver I.B.
        • Wan M.
        • Tran C.Q.
        • Francke U.
        • Zoghbi H.Y.
        Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein.
        Nat Genet. 1999; 23: 185-188
        • Obata K.
        • Matsuishi T.
        • Yamashita Y.
        • Fukuda T.
        • Kuwajima K.
        • Horiuchi I.
        • et al.
        Mutation analysis of the methyl-CpG binding protein gene (MECP2) in patients with Rett syndrome.
        J Med Genet. 2000; 37: 608-610
        • Huppke P.
        • Laccone F.
        • Kramer N.
        • Engel W.
        • Hanefeld F.
        Rett syndrome: analysis of MECP2 and clinical characterisation of 31 patients.
        Hum Mol Genet. 2000; 9: 1369-1375
        • De Bona C.
        • Zappella M.
        • Hayek G.
        • Meloni I.
        • Vitelli F.
        • Bruttini M.
        • et al.
        Preserved speech variant is allelic of classical Rett syndrome.
        Eur J Hum Genet. 2000; 8: 325-330
        • The Rett Syndrome Diagnostic Criteria Work Group
        Diagnostic criteria for Rett syndrome.
        Ann Neurol. 1988; 23: 425-428
      1. Nielsen JB, Henriksen KF, Ravn K, Tommerup N, Schwartz M. A patient with the preserved speech variant. An updated survey of the mutations in the Danish patient group. World Congress on Rett syndrome, 2000.

        • Cheadle J.P.
        • Gill H.
        • Fleming N.
        • Maynard J.
        • Kerr A.
        • Leonard H.
        • et al.
        Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.
        Hum Mol Genet. 2000; 9: 1119-1129